This compound is primarily utilized in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs). Its structure makes it a valuable intermediate in the production of complex molecules, especially those targeting neurological and cardiovascular diseases. The tert-butoxycarbonyl (Boc) protecting group ensures selective reactions during synthesis, enhancing the efficiency of multi-step processes. Additionally, its chiral centers are crucial for creating enantiomerically pure drugs, which are essential for optimizing therapeutic efficacy and minimizing side effects. It is also employed in research settings for studying enzyme interactions and receptor binding due to its specific stereochemistry.